Wanbury Limited (WANBURY) - Net Assets
Based on the latest financial reports, Wanbury Limited (WANBURY) has net assets worth Rs1.07 Billion INR (≈ $11.60 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs4.57 Billion ≈ $49.38 Million USD) and total liabilities (Rs3.49 Billion ≈ $37.78 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how tangible is Wanbury Limited's equity to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs1.07 Billion |
| % of Total Assets | 23.49% |
| Annual Growth Rate | -2.77% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 69.93 |
Wanbury Limited - Net Assets Trend (2006–2025)
This chart illustrates how Wanbury Limited's net assets have evolved over time, based on quarterly financial data. See Wanbury Limited liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Wanbury Limited (2006–2025)
The table below shows the annual net assets of Wanbury Limited from 2006 to 2025. For live valuation and market cap data, see WANBURY market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | Rs592.72 Million ≈ $6.41 Million |
+112.13% |
| 2024-03-31 | Rs279.41 Million ≈ $3.02 Million |
+185.15% |
| 2023-03-31 | Rs-328.16 Million ≈ $-3.55 Million |
-40.12% |
| 2022-03-31 | Rs-234.20 Million ≈ $-2.53 Million |
+85.01% |
| 2021-03-31 | Rs-1.56 Billion ≈ $-16.90 Million |
-8.92% |
| 2020-03-31 | Rs-1.43 Billion ≈ $-15.51 Million |
+31.45% |
| 2019-03-31 | Rs-2.09 Billion ≈ $-22.63 Million |
-13.32% |
| 2018-03-31 | Rs-1.85 Billion ≈ $-19.97 Million |
-20.49% |
| 2017-03-31 | Rs-1.53 Billion ≈ $-16.58 Million |
+6.10% |
| 2016-03-31 | Rs-1.63 Billion ≈ $-17.65 Million |
+7.88% |
| 2015-03-31 | Rs-1.77 Billion ≈ $-19.16 Million |
-7.35% |
| 2014-03-31 | Rs-1.65 Billion ≈ $-17.85 Million |
-675.06% |
| 2013-03-31 | Rs-212.95 Million ≈ $-2.30 Million |
-129.95% |
| 2012-03-31 | Rs711.13 Million ≈ $7.69 Million |
-32.26% |
| 2011-03-31 | Rs1.05 Billion ≈ $11.35 Million |
-45.45% |
| 2010-03-31 | Rs1.92 Billion ≈ $20.81 Million |
+21.46% |
| 2009-03-31 | Rs1.58 Billion ≈ $17.13 Million |
+22.71% |
| 2007-03-31 | Rs1.29 Billion ≈ $13.96 Million |
+27.66% |
| 2006-03-31 | Rs1.01 Billion ≈ $10.94 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Wanbury Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 108352500000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Rs327.70 Million | 55.29% |
| Other Components | Rs1.35 Billion | 227.52% |
| Total Equity | Rs592.72 Million | 100.00% |
Wanbury Limited Competitors by Market Cap
The table below lists competitors of Wanbury Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Alpha Astika Akinita S.A
AT:ASTAK
|
$101.36 Million |
|
Spheria Emerging Companies Ltd
AU:SEC
|
$101.36 Million |
|
Ablerex Electronics Co Ltd
TWO:3628
|
$101.37 Million |
|
Suraj Estate Developers Ltd.
NSE:SURAJEST
|
$101.43 Million |
|
Fuzetec Technology Co Ltd
TWO:6642
|
$101.22 Million |
|
Expensify Inc
NASDAQ:EXFY
|
$101.13 Million |
|
Fine DNC Co. Ltd
KQ:049120
|
$101.12 Million |
|
Emerging Display Technologies Corp
TW:3038
|
$101.11 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Wanbury Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 279,414,000 to 592,718,000, a change of 313,304,000 (112.1%).
- Net income of 305,301,000 contributed positively to equity growth.
- Share repurchases of 250,000 reduced equity.
- New share issuances of 250,000 increased equity.
- Other comprehensive income decreased equity by 179,638,000.
- Other factors increased equity by 187,641,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs305.30 Million | +51.51% |
| Share Repurchases | Rs250.00K | -0.04% |
| Share Issuances | Rs250.00K | +0.04% |
| Other Comprehensive Income | Rs-179.64 Million | -30.31% |
| Other Changes | Rs187.64 Million | +31.66% |
| Total Change | Rs- | 112.13% |
Book Value vs Market Value Analysis
This analysis compares Wanbury Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 15.37x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 2.94x to 15.37x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2006-03-31 | Rs91.16 | Rs267.95 | x |
| 2007-03-31 | Rs97.01 | Rs267.95 | x |
| 2009-03-31 | Rs102.66 | Rs267.95 | x |
| 2010-03-31 | Rs125.81 | Rs267.95 | x |
| 2011-03-31 | Rs84.22 | Rs267.95 | x |
| 2012-03-31 | Rs30.23 | Rs267.95 | x |
| 2013-03-31 | Rs-27.59 | Rs267.95 | x |
| 2015-03-31 | Rs-97.12 | Rs267.95 | x |
| 2016-03-31 | Rs-94.53 | Rs267.95 | x |
| 2017-03-31 | Rs-73.66 | Rs267.95 | x |
| 2018-03-31 | Rs-77.86 | Rs267.95 | x |
| 2019-03-31 | Rs-88.23 | Rs267.95 | x |
| 2020-03-31 | Rs-59.86 | Rs267.95 | x |
| 2021-03-31 | Rs-62.48 | Rs267.95 | x |
| 2022-03-31 | Rs-7.25 | Rs267.95 | x |
| 2023-03-31 | Rs-1.88 | Rs267.95 | x |
| 2024-03-31 | Rs8.44 | Rs267.95 | x |
| 2025-03-31 | Rs17.43 | Rs267.95 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Wanbury Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 51.51%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.09%
- • Asset Turnover: 1.45x
- • Equity Multiplier: 6.98x
- Recent ROE (51.51%) is above the historical average (5.61%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2006 | 10.61% | 9.86% | 0.56x | 1.93x | Rs6.16 Million |
| 2007 | 16.13% | 14.48% | 0.45x | 2.48x | Rs79.14 Million |
| 2009 | -21.31% | -13.23% | 0.29x | 5.53x | Rs-472.21 Million |
| 2010 | 4.55% | 1.78% | 0.59x | 4.36x | Rs-100.66 Million |
| 2011 | -67.73% | -21.63% | 0.51x | 6.15x | Rs-961.58 Million |
| 2012 | -87.50% | -10.07% | 0.48x | 18.24x | Rs-433.39 Million |
| 2013 | 0.00% | -19.00% | 0.59x | 0.00x | Rs-824.34 Million |
| 2014 | 0.00% | -19.30% | 1.09x | 0.00x | Rs-659.68 Million |
| 2015 | 0.00% | 1.28% | 0.63x | 0.00x | Rs225.98 Million |
| 2016 | 0.00% | -1.69% | 1.11x | 0.00x | Rs117.30 Million |
| 2017 | 0.00% | 14.45% | 1.04x | 0.00x | Rs773.43 Million |
| 2018 | 0.00% | -8.70% | 1.35x | 0.00x | Rs-135.40 Million |
| 2019 | 0.00% | -6.42% | 1.35x | 0.00x | Rs-39.20 Million |
| 2020 | 0.00% | 17.78% | 1.30x | 0.00x | Rs788.07 Million |
| 2021 | 0.00% | -3.26% | 1.34x | 0.00x | Rs30.19 Million |
| 2022 | 0.00% | 15.94% | 1.45x | 0.00x | Rs838.16 Million |
| 2023 | 0.00% | -2.09% | 1.64x | 0.00x | Rs-97.80 Million |
| 2024 | 200.26% | 9.74% | 1.67x | 12.29x | Rs531.62 Million |
| 2025 | 51.51% | 5.09% | 1.45x | 6.98x | Rs246.03 Million |
Industry Comparison
This section compares Wanbury Limited's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $21,181,792,391
- Average return on equity (ROE) among peers: 16.24%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Wanbury Limited (WANBURY) | Rs1.07 Billion | 10.61% | 3.26x | $101.25 Million |
| Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) | $1.14 Billion | 5.77% | 1.16x | $24.73 Million |
| Aarti Drugs Limited (AARTIDRUGS) | $13.69 Billion | 12.28% | 0.88x | $362.94 Million |
| Aarti Pharmalabs Limited (AARTIPHARM) | $2.27 Million | -2.03% | 0.10x | $635.44 Million |
| Abbott India Limited (ABBOTINDIA) | $28.20 Billion | 28.32% | 0.50x | $5.96 Billion |
| Ajanta Pharma Limited (AJANTPHARM) | $35.67 Billion | 22.88% | 0.30x | $4.16 Billion |
| Akums Drugs and Pharmaceutical (AKUMS) | $30.64 Billion | 11.04% | 0.34x | $979.45 Million |
| Alkem Laboratories Limited (ALKEM) | $63.09 Billion | 17.86% | 0.58x | $6.91 Billion |
| Amrutanjan Health Care Limited (AMRUTANJAN) | $234.13 Million | 25.26% | 0.77x | $166.82 Million |
| Alembic Pharmaceuticals Limited (APLLTD) | $31.90 Billion | 25.98% | 0.88x | $1.59 Billion |
| Aurobindo Pharma Limited (AUROPHARMA) | $7.25 Billion | 14.99% | 1.57x | $8.85 Billion |
About Wanbury Limited
Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. The company offers formulations for anti-infectives, pain and analgesics, respiratory, gastroenterology, gynecology, rheumatology, and central nervous system, as well as for vitamins, minerals, and nutrition. It also provides API products for antidiabetics, antihistamines,… Read more